Clinical Trial Update: Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction [Phase 3]

View source ↗

Summary

Phase 3 cross-over study evaluating albuterol HFA for exercise-induced bronchoconstriction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Albuterol-HFA (albuterol)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma, Bronchospasm | Phase 3 | Status: TERMINATED